190 related articles for article (PubMed ID: 11575285)
1. Effects of inhaled glucocorticoids on bone density in premenopausal women.
Israel E; Banerjee TR; Fitzmaurice GM; Kotlov TV; LaHive K; LeBoff MS
N Engl J Med; 2001 Sep; 345(13):941-7. PubMed ID: 11575285
[TBL] [Abstract][Full Text] [Related]
2. Antiresorptive therapy in asthmatic patients receiving high-dose inhaled steroids: a prospective study for 18 months.
Wang WQ; Ip MS; Tsang KW; Lam KS
J Allergy Clin Immunol; 1998 Apr; 101(4 Pt 1):445-50. PubMed ID: 9564795
[TBL] [Abstract][Full Text] [Related]
3. Primary prevention of glucocorticoid-induced osteoporosis with intravenous pamidronate and calcium: a prospective controlled 1-year study comparing a single infusion, an infusion given once every 3 months, and calcium alone.
Boutsen Y; Jamart J; Esselinckx W; Devogelaer JP
J Bone Miner Res; 2001 Jan; 16(1):104-12. PubMed ID: 11149473
[TBL] [Abstract][Full Text] [Related]
4. Mineral status of COPD patients under long-term inhaled corticosteroid therapy.
Buyukkaplan US; Akkaya A; Yildiz M; Bircan A; Aksoy Dogan A; Ozturk O
J Prosthodont; 2008 Aug; 17(6):462-7. PubMed ID: 18573148
[TBL] [Abstract][Full Text] [Related]
5. Early changes in biochemical markers of bone turnover predict the long-term response to alendronate therapy in representative elderly women: a randomized clinical trial.
Greenspan SL; Parker RA; Ferguson L; Rosen HN; Maitland-Ramsey L; Karpf DB
J Bone Miner Res; 1998 Sep; 13(9):1431-8. PubMed ID: 9738515
[TBL] [Abstract][Full Text] [Related]
6. Bone loss and inhaled glucocorticoids.
van Staa TP; Leufkens B; Cooper C
N Engl J Med; 2002 Feb; 346(7):533-5. PubMed ID: 11858218
[No Abstract] [Full Text] [Related]
7. Bone mineral density and bone turnover in asthmatics treated with long-term inhaled or oral glucocorticoids.
Ebeling PR; Erbas B; Hopper JL; Wark JD; Rubinfeld AR
J Bone Miner Res; 1998 Aug; 13(8):1283-9. PubMed ID: 9718197
[TBL] [Abstract][Full Text] [Related]
8. Four years follow-up of bone mineral density change in premenopausal women with systemic lupus erythematosus.
Uaratanawong S; Deesomchok U; Hiransuttikul N; Uaratanawong S
J Med Assoc Thai; 2004 Nov; 87(11):1374-9. PubMed ID: 15825716
[TBL] [Abstract][Full Text] [Related]
9. Bone mineral density changes and bone turnover in thyroid carcinoma patients treated with supraphysiologic doses of thyroxine.
Karner I; Hrgović Z; Sijanović S; Buković D; Klobucar A; Usadel KH; Fassbender WJ
Eur J Med Res; 2005 Nov; 10(11):480-8. PubMed ID: 16354602
[TBL] [Abstract][Full Text] [Related]
10. Influence of inhaled corticosteroids and dietary intake on bone density and metabolism in patients with moderate to severe asthma.
Gagnon L; Boulet LP; Brown J; Desrosiers T
J Am Diet Assoc; 1997 Dec; 97(12):1401-6. PubMed ID: 9404337
[TBL] [Abstract][Full Text] [Related]
11. Increased bone turnover in late postmenopausal women is a major determinant of osteoporosis.
Garnero P; Sornay-Rendu E; Chapuy MC; Delmas PD
J Bone Miner Res; 1996 Mar; 11(3):337-49. PubMed ID: 8852944
[TBL] [Abstract][Full Text] [Related]
12. Effect of calcium supplementation on bone loss in postmenopausal women.
Reid IR; Ames RW; Evans MC; Gamble GD; Sharpe SJ
N Engl J Med; 1993 Feb; 328(7):460-4. PubMed ID: 8421475
[TBL] [Abstract][Full Text] [Related]
13. Bone loss in premenopausal women on long-term suppressive therapy with thyroid hormone.
Sijanovic S; Karner I
Medscape Womens Health; 2001 Oct; 6(5):3. PubMed ID: 11698925
[TBL] [Abstract][Full Text] [Related]
14. [Systemic side effects of long-term treatment with low dose inhaled corticosteroids in children with asthma].
Chen A; Chen R; Zhong N
Zhonghua Jie He He Hu Xi Za Zhi; 2001 Dec; 24(12):740-3. PubMed ID: 11930704
[TBL] [Abstract][Full Text] [Related]
15. Bone turnover and density in obese premenopausal women during moderate weight loss and calcium supplementation.
Shapses SA; Von Thun NL; Heymsfield SB; Ricci TA; Ospina M; Pierson RN; Stahl T
J Bone Miner Res; 2001 Jul; 16(7):1329-36. PubMed ID: 11450709
[TBL] [Abstract][Full Text] [Related]
16. Effects of once-weekly oral alendronate on bone in children on glucocorticoid treatment.
Rudge S; Hailwood S; Horne A; Lucas J; Wu F; Cundy T
Rheumatology (Oxford); 2005 Jun; 44(6):813-8. PubMed ID: 15695300
[TBL] [Abstract][Full Text] [Related]
17. Intermittent etidronate therapy to prevent corticosteroid-induced osteoporosis.
Adachi JD; Bensen WG; Brown J; Hanley D; Hodsman A; Josse R; Kendler DL; Lentle B; Olszynski W; Ste-Marie LG; Tenenhouse A; Chines AA
N Engl J Med; 1997 Aug; 337(6):382-7. PubMed ID: 9241127
[TBL] [Abstract][Full Text] [Related]
18. Bone mineral density and history of oral contraceptive use.
Fortney JA; Feldblum PJ; Talmage RV; Zhang J; Godwin SE
J Reprod Med; 1994 Feb; 39(2):105-9. PubMed ID: 8169923
[TBL] [Abstract][Full Text] [Related]
19. Long-term effects of infliximab on bone and cartilage turnover markers in patients with rheumatoid arthritis.
Chopin F; Garnero P; le Henanff A; Debiais F; Daragon A; Roux C; Sany J; Wendling D; Zarnitsky C; Ravaud P; Thomas T
Ann Rheum Dis; 2008 Mar; 67(3):353-7. PubMed ID: 17644538
[TBL] [Abstract][Full Text] [Related]
20. The long-term effect of menopause on postmenopausal bone loss in Japanese women: results from a prospective study.
Okano H; Mizunuma H; Soda M; Kagami I; Miyamoto S; Ohsawa M; Ibuki Y; Shiraki M; Suzuki T; Shibata H
J Bone Miner Res; 1998 Feb; 13(2):303-9. PubMed ID: 9495525
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
